Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria.

Nosyk B, Audoin B, Beyrer C, Cahn P, Granich R, Havlir D, Katabira E, Lange J, Lima VD, Patterson T, Strathdee SA, Williams B, Montaner J.

AIDS. 2013 Apr 24;27(7):1159-65. doi: 10.1097/QAD.0b013e32835f1d68. Review.

2.

HIV treatment as prevention among injection drug users.

Wood E, Milloy MJ, Montaner JS.

Curr Opin HIV AIDS. 2012 Mar;7(2):151-6. doi: 10.1097/COH.0b013e32834f9927. Review.

PMID:
22227587
3.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
4.

The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

McCabe CJ, Goldie SJ, Fisman DN.

PLoS One. 2010 Apr 13;5(4):e10154. doi: 10.1371/journal.pone.0010154.

5.

Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa.

Auvert B, Males S, Puren A, Taljaard D, Caraël M, Williams B.

J Acquir Immune Defic Syndr. 2004 May 1;36(1):613-21.

6.

Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART).

Purohit V, Rapaka RS, Schnur P, Shurtleff D.

Life Sci. 2011 May 23;88(21-22):909-16. doi: 10.1016/j.lfs.2011.03.022. Epub 2011 Apr 6.

PMID:
21477599
7.

The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men.

Zaric GS, Bayoumi AM, Brandeau ML, Owens DK.

Med Decis Making. 2008 May-Jun;28(3):359-76. doi: 10.1177/0272989X07312714. Epub 2008 Mar 18.

8.

Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.

Gbabe OF, Okwundu CI, Dedicoat M, Freeman EE.

Cochrane Database Syst Rev. 2014;(9):CD003256. Review.

PMID:
25313415
9.

Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.

French CE, Tookey PA, Cortina-Borja M, de Ruiter A, Townsend CL, Thorne C.

Antivir Ther. 2013;18(2):183-92. doi: 10.3851/IMP2327. Epub 2012 Aug 22.

PMID:
23475123
10.

HIV treatment as prevention: the utility and limitations of ecological observation.

Smith MK, Powers KA, Muessig KE, Miller WC, Cohen MS.

PLoS Med. 2012;9(7):e1001260. doi: 10.1371/journal.pmed.1001260. Epub 2012 Jul 10. Review.

11.
12.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
13.

Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1.

14.

Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial.

Isanaka S, Mugusi F, Hawkins C, Spiegelman D, Okuma J, Aboud S, Guerino C, Fawzi WW.

JAMA. 2012 Oct 17;308(15):1535-44. doi: 10.1001/jama.2012.13083.

15.

Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China.

Wang X, Yang L, Li H, Zuo L, Liang S, Liu W, Dong Y, Yang S, Shang H, Li J, Kang L, Zhong P, Zheng W, Liao L, Xing H, Chen RY, Ruan Y, Shao Y.

Curr HIV Res. 2011 Mar;9(2):103-11.

PMID:
21361864
16.

Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.

Resino S, Resino R, Micheloud D, Gurbindo Gutiérrez D, Léon JA, Ramos JT, Ciria L, de José I, Mellado J, Muñoz-Fernández A; Spanish Group of Paediatric HIV Infection.

Clin Infect Dis. 2006 Mar 15;42(6):862-9. Epub 2006 Feb 9.

PMID:
16477566
17.

Highly active antiretroviral treatment for the prevention of HIV transmission.

Granich R, Crowley S, Vitoria M, Lo YR, Souteyrand Y, Dye C, Gilks C, Guerma T, De Cock KM, Williams B.

J Int AIDS Soc. 2010 Jan 12;13:1. doi: 10.1186/1758-2652-13-1.

18.

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.

J Infect Dis. 2009 Nov 15;200(10):1490-7. doi: 10.1086/644598.

PMID:
19832114
19.

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16. doi: 10.1097/QAI.0b013e3181b323ff.

PMID:
19730269
20.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490

Supplemental Content

Support Center